Latest market price
634.89
-2.68-0.42%
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 23.21 | EPS (ttm) | 27.47 | Insider Own | 6.86% | Shs Outstand | 42.76M | Perf Week | 1.28% |
| Market Cap | 27.26B | Forward P/E | 19.81 | EPS next Y | 32.19 | Insider Trans | -0.10% | Shs Float | 42.64M | Perf Month | 16.98% |
| Enterprise Value | 29.57B | PEG | 2.07 | EPS next Q | 5.60 | Short Float | 5.01% | Perf Quarter | 17.69% | ||
| Income | 1.21B | P/S | 2.10 | EPS this Y | 12.97% | Short Ratio | 3.71 | Perf Half Y | 19.22% | ||
| Sales | 12.96B | P/B | 10.31 | EPS next Y | 10.91% | ROA | 17.38% | Short Interest | 2.13M | Perf YTD | 4.94% |
| Book/sh | 61.84 | P/C | 127.98 | EPS next 5Y | 11.21% | ROE | 45.40% | 52W High | 714.97 -11.20% | Perf Year | 22.12% |
| Cash/sh | 4.98 | P/FCF | 25.55 | EPS past 3/5Y | 2.21% 52.49% | ROIC | 23.11% | 52W Low | 443.60 43.12% | Perf 3Y | 67.13% |
| Dividend Est. | — | EV/EBITDA | 15.24 | Sales past 3/5Y | 6.68% 15.04% | Gross Margin | 39.32% | Volatility | 3.13% 2.74% | Perf 5Y | 73.44% |
| Dividend TTM | — | EV/Sales | 2.28 | EPS Y/Y TTM | 5.33% | Oper. Margin | 12.56% | ATR (14) | 17.26 | Perf 10Y | 151.69% |
| Dividend Ex-Date | Mar 16, 2012 | Quick Ratio | 0.29 | Sales Y/Y TTM | 11.17% | Profit Margin | 9.34% | RSI (14) | 65.43 | Recom | 2.38 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.35 | EPS Q/Q | 13.32% | SMA20 | 4.81% | Beta | 0.82 | Target Price | 630.27 |
| Payout | 0.00% | Debt/Eq | 0.95 | Sales Q/Q | 8.90% | SMA50 | 11.56% | Rel Volume | 0.81 | Prev Close | 637.57 |
| Employees | 65,000 | LT Debt/Eq | 0.71 | Earnings | Dec 03 | SMA200 | 14.89% | Avg Volume | 555.29K | Price | 634.89 |
| IPO Date | Oct 25, 2007 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 5.27% 1.59% | Net Debt/EBITDA | 1.19 | Volume | 447,123 | Change | -0.42% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-23-26 | Reiterated | Jefferies | Buy | $650 → $730 |
| Sep-15-26 | Upgrade | Wells Fargo | Underweight → Equal Weight | $425 → $525 |
| Sep-08-26 | Initiated | BMO Capital | Market Perform | $385 → $580 |
| Aug-28-26 | Reiterated | UBS | Buy | $710 → $631 |
| Aug-28-26 | Reiterated | Jefferies | Buy | $700 → $650 |
| Aug-28-26 | Reiterated | Raymond James | Strong Buy | $790 → $700 |
| Aug-28-26 | Reiterated | Barclays | Overweight | $712 → $645 |
| Aug-28-26 | Reiterated | Goldman Sachs | Buy | $652 → $667 |
| Aug-25-26 | Reiterated | Deutsche Bank | Buy | $732 → $695 |
| Jun-18-26 | Reiterated | Argus Research | Buy | $615 → $550 |
Latest News· Times ET
Today
09:56AM
09:00AM
Nov-02-26
Oct-29-26
Oct-28-26
04:45PM
Oct-27-26
Oct-27-2610:41AM
Oct-26-26
Oct-26-2609:16AM
Oct-23-26
Oct-23-2610:01AM
Oct-22-26
Oct-20-26
10:31AM
Company
Ulta Beauty, Inc. functions as a prominent beauty product retailer throughout the United States. Its physical locations feature a broad assortment of goods, including cosmetics, perfumes, skincare, haircare items, bath and body essentials, and professional salon styling instruments. Additionally, they provide a comprehensive suite of salon services, encompassing hair, skin, makeup, brow, and nail treatments. The company further offers its proprietary label products, such as the Ulta Beauty Collection for cosmetics, skincare, and bath items, alongside other Ulta Beauty branded merchandise and gift options. As of March 10, 2022, Ulta Beauty operated 1,308 retail stores across all 50 U.S. states. Its products are also available for purchase via its website, ulta.com, and through its mobile applications. Incorporated in 1990, the enterprise was initially known as Ulta Salon, Cosmetics & Fragrance, Inc., before officially changing its name to Ulta Beauty, Inc. in January 2017. Its corporate base is located in Bolingbrook, Illinois.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 1/31/2020 | FY 2018 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,956 | 12,393 | 11,296 | 11,207 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 7,862 | 7,548 | 6,908 | 6,826 | — | — | — | — | — | |
| Gross Profit | 5,095 | 4,845 | 4,387 | 4,381 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,462 | 3,296 | 2,809 | 2,695 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 1,628 | 1,549 | 1,579 | 1,687 | — | — | — | — | — | |
| Interest Expense | 12 | 2 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -16 | -16 | 1 | 9 | — | — | — | — | — | |
| Net Income Before Taxes | 1,601 | 1,531 | 1,580 | 1,696 | — | — | — | — | — | |
| Income Taxes | 388 | 374 | 379 | 405 | — | — | — | — | — | |
| Consolidated Net Income | 1,210 | 1,153 | 1,201 | 1,291 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,213 | 1,157 | 1,201 | 1,291 | — | — | — | — | — | |
| Net Income | 1,210 | 1,153 | 1,201 | 1,291 | — | — | — | — | — | |
| EPS (Recurring) | 27.55 | 25.72 | 25.44 | 26.18 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 27.55 | 25.72 | 25.44 | 26.18 | — | — | — | — | — | |
| EPS (Diluted) | 27.47 | 25.64 | 25.34 | 26.03 | — | — | — | — | — | |
| EBITDA | 1,940 | 1,834 | 1,847 | 1,939 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 23.11 | 25.25 | 16.26 | 19.41 | — | — | — | — | — | |
| Price To Sales Ratio | 2.11 | 2.35 | 1.71 | 2.21 | — | — | — | — | — | |
| Gross Margin | 39.33 | 39.09 | 38.84 | 39.09 | — | — | — | — | — | |
| Operating Margin | 12.57 | 12.50 | 13.98 | 15.05 | — | — | — | — | — | |
| Net Margin | 9.34 | 9.30 | 10.63 | 11.52 | — | — | — | — | — | |
| Shares Outstanding | 43 | 45 | 47 | 49 | — | — | — | — | — | |
| Market Capitalization | 27,300 | 29,131 | 19,371 | 24,761 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Steelman Kecia | President and CEO | Sep 17 '26 | Sale | 545.88 | 2,000 | 1,091,766 | 40,489 | Sep 21 |
| Nagler Lorna | Director | Sep 11 '26 | Sale | 537.31 | 600 | 322,388 | 7,168 | Sep 14 |
| MRKONIC GEORGE R JR | Director | Jun 15 '26 | Sale | 475.84 | 383 | 182,247 | 2,404 | Jun 16 |
| MRKONIC GEORGE R JR | Director | Apr 07 '26 | Sale | 539.29 | 452 | 243,759 | 2,383 | Apr 07 |
| Smith Mike C. | Director | Sep 04 '25 | Sale | 528.43 | 500 | 264,215 | 2,263 | Sep 08 |
| Caro Jodi J | GC, Chief Risk & Compl. Ofc. | Apr 01 '25 | Option Exercise | 174.45 | 902 | 157,354 | 8,534 | Apr 02 |
| Caro Jodi J | GC, Chief Risk & Compl. Ofc. | Apr 01 '25 | Sale | 369.16 | 902 | 332,984 | 7,632 | Apr 02 |
| Steelman Kecia | President and CEO | Mar 20 '25 | Buy | 346.89 | 1,440 | 499,528 | 16,992 | Mar 24 |
| Halligan Catherine Ann | Director | Jul 02 '24 | Sale | 390.08 | 100 | 39,008 | 2,017 | Jul 03 |
| Caro Jodi J | GC, Chief Risk & Compl. Ofc. | Jun 25 '24 | Sale | 388.68 | 650 | 252,639 | 6,801 | Jun 27 |
| MRKONIC GEORGE R JR | Director | Jun 04 '24 | Sale | 389.34 | 397 | 154,568 | 2,000 | Jun 05 |
| Ryan Anita Jane | Chief Human Resources Officer | Mar 19 '24 | Option Exercise | 239.71 | 2,852 | 683,663 | 5,807 | Mar 21 |
| Steelman Kecia | President and COO | Mar 19 '24 | Sale | 526.39 | 20,950 | 11,027,871 | 10,494 | Mar 21 |
| Steelman Kecia | President and COO | Mar 19 '24 | Option Exercise | 280.38 | 13,587 | 3,809,524 | 31,444 | Mar 21 |
| Ryan Anita Jane | Chief Human Resources Officer | Mar 19 '24 | Sale | 525.25 | 3,102 | 1,629,338 | 2,705 | Mar 21 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.